vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and SOUTHSIDE BANCSHARES INC (SBSI). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $62.8M, roughly 1.3× SOUTHSIDE BANCSHARES INC). SOUTHSIDE BANCSHARES INC runs the higher net margin — 33.4% vs -38.1%, a 71.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -4.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -0.2%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Southside Bancshares Inc. is a U.S.-based bank holding company primarily operating in Texas. It offers a full range of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial loans, and wealth management solutions, serving retail customers, small and medium-sized enterprises and local community groups.
PRCT vs SBSI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $62.8M |
| Net Profit | $-31.6M | $21.0M |
| Gross Margin | 64.9% | — |
| Operating Margin | -4.1% | 39.4% |
| Net Margin | -38.1% | 33.4% |
| Revenue YoY | 20.2% | -4.8% |
| Net Profit YoY | -27.9% | -3.7% |
| EPS (diluted) | $-0.56 | $0.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $62.8M | ||
| Q3 25 | $83.3M | $43.7M | ||
| Q2 25 | $79.2M | $66.4M | ||
| Q1 25 | $69.2M | $64.1M | ||
| Q4 24 | $68.2M | $66.0M | ||
| Q3 24 | $58.4M | $63.6M | ||
| Q2 24 | $53.4M | $65.2M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | $21.0M | ||
| Q3 25 | $-21.4M | $4.9M | ||
| Q2 25 | $-19.6M | $21.8M | ||
| Q1 25 | $-24.7M | $21.5M | ||
| Q4 24 | $-18.9M | $21.8M | ||
| Q3 24 | $-21.0M | $20.5M | ||
| Q2 24 | $-25.6M | $24.7M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 65.4% | — | ||
| Q1 25 | 63.9% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 59.0% | — |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 39.4% | ||
| Q3 25 | -27.8% | 11.7% | ||
| Q2 25 | -28.0% | 40.0% | ||
| Q1 25 | -39.7% | 40.9% | ||
| Q4 24 | -28.9% | 40.1% | ||
| Q3 24 | -38.4% | 39.2% | ||
| Q2 24 | -50.3% | 45.9% |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | 33.4% | ||
| Q3 25 | -25.7% | 11.2% | ||
| Q2 25 | -24.7% | 32.8% | ||
| Q1 25 | -35.8% | 33.6% | ||
| Q4 24 | -27.6% | 33.0% | ||
| Q3 24 | -35.9% | 32.3% | ||
| Q2 24 | -48.0% | 37.9% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $0.70 | ||
| Q3 25 | $-0.38 | $0.16 | ||
| Q2 25 | $-0.35 | $0.72 | ||
| Q1 25 | $-0.45 | $0.71 | ||
| Q4 24 | $-0.34 | $0.71 | ||
| Q3 24 | $-0.40 | $0.68 | ||
| Q2 24 | $-0.50 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $389.8M |
| Total DebtLower is stronger | $51.7M | $300.0M |
| Stockholders' EquityBook value | $347.7M | $847.6M |
| Total Assets | $487.1M | $8.5B |
| Debt / EquityLower = less leverage | 0.15× | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $389.8M | ||
| Q3 25 | $294.3M | $466.9M | ||
| Q2 25 | $302.7M | $390.1M | ||
| Q1 25 | $316.2M | $431.0M | ||
| Q4 24 | $333.7M | $426.2M | ||
| Q3 24 | $196.8M | $486.3M | ||
| Q2 24 | $214.1M | $452.0M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | $300.0M | ||
| Q3 25 | $51.6M | $299.9M | ||
| Q2 25 | $51.5M | $152.4M | ||
| Q1 25 | $51.5M | $152.4M | ||
| Q4 24 | $51.5M | $152.3M | ||
| Q3 24 | $51.4M | $152.3M | ||
| Q2 24 | $51.4M | $152.2M |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $847.6M | ||
| Q3 25 | $380.3M | $834.9M | ||
| Q2 25 | $385.8M | $807.2M | ||
| Q1 25 | $389.2M | $816.6M | ||
| Q4 24 | $402.2M | $811.9M | ||
| Q3 24 | $241.2M | $805.3M | ||
| Q2 24 | $251.8M | $801.0M |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $8.5B | ||
| Q3 25 | $511.5M | $8.4B | ||
| Q2 25 | $513.1M | $8.3B | ||
| Q1 25 | $519.4M | $8.3B | ||
| Q4 24 | $534.0M | $8.5B | ||
| Q3 24 | $374.1M | $8.4B | ||
| Q2 24 | $374.4M | $8.4B |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | 0.35× | ||
| Q3 25 | 0.14× | 0.36× | ||
| Q2 25 | 0.13× | 0.19× | ||
| Q1 25 | 0.13× | 0.19× | ||
| Q4 24 | 0.13× | 0.19× | ||
| Q3 24 | 0.21× | 0.19× | ||
| Q2 24 | 0.20× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $93.8M |
| Free Cash FlowOCF − Capex | — | $73.5M |
| FCF MarginFCF / Revenue | — | 117.0% |
| Capex IntensityCapex / Revenue | — | 32.4% |
| Cash ConversionOCF / Net Profit | — | 4.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $130.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $93.8M | ||
| Q3 25 | $-6.6M | $40.2M | ||
| Q2 25 | $-15.0M | $5.9M | ||
| Q1 25 | $-17.0M | $23.9M | ||
| Q4 24 | $-32.4M | $101.8M | ||
| Q3 24 | $-18.8M | $-11.7M | ||
| Q2 24 | $-15.7M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | $73.5M | ||
| Q3 25 | $-9.5M | $37.4M | ||
| Q2 25 | $-17.8M | $-2.0M | ||
| Q1 25 | $-18.8M | $21.5M | ||
| Q4 24 | $-33.6M | $90.7M | ||
| Q3 24 | $-19.0M | $-14.2M | ||
| Q2 24 | $-16.8M | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | 117.0% | ||
| Q3 25 | -11.4% | 85.5% | ||
| Q2 25 | -22.5% | -3.0% | ||
| Q1 25 | -27.2% | 33.6% | ||
| Q4 24 | -49.2% | 137.4% | ||
| Q3 24 | -32.6% | -22.3% | ||
| Q2 24 | -31.4% | 23.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 32.4% | ||
| Q3 25 | 3.4% | 6.5% | ||
| Q2 25 | 3.5% | 12.0% | ||
| Q1 25 | 2.7% | 3.8% | ||
| Q4 24 | 1.7% | 16.9% | ||
| Q3 24 | 0.4% | 3.8% | ||
| Q2 24 | 2.0% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.47× | ||
| Q3 25 | — | 8.18× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 4.67× | ||
| Q3 24 | — | -0.57× | ||
| Q2 24 | — | 0.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
SBSI
Segment breakdown not available.
